Cj. Wilson et al., FIRST REPORT OF HURTHLE CELL-CARCINOMA REVEALED BY OCTREOTIDE SCANNING, The Annals of otology, rhinology & laryngology, 107(10), 1998, pp. 847-850
Octreotide is an 8-chain amino acid analog of somatostatin. Somatostat
in and its receptors occur naturally in multiple sites within the body
and serve a suppressive role in endocrine hormone release. When octre
otide, which has a considerably longer half-life than somatostatin, is
combined with a radioactive isotope, receptor-based imaging can be pe
rformed to visualize tumors with high concentrations of somatostatin r
eceptors. Tumors of neural crest origin - pituitary adenomas, islet ce
ll tumors, medullary thyroid carcinomas, pheochromocytomas, carcinoids
, and paragangliomas - all express high levels of somatostatin recepto
rs. We present the first reported positive octreotide scan of a Hurthl
e cell carcinoma of the thyroid and, more important, discuss the role
of octreotide scanning in otolaryngology, which has not yet been revie
wed by our literature.